Oncology Clinical Trials

Study 16
A phase II, double-blind, randomized, placebo-controlled study to assess the efficacy of AZD6244 (hyd-sulfate) in combination with docetaxel, compared with docetaxel alone, in second-line patients with KRAS mutation-positive local advanced or metastatic non–small-cell lung cancer (Stage IIIB - IV).

Study 41
A phase II, open label, randomized comparative multi-center study to compare the efficacy and tolerability of olaparib in combination with paclitaxel and carboplatin versus paclitaxel and carboplatin alone in patients with platinum sensitive advanced serous ovarian cancer.